| Naslov: | The association of KEAP1 and NFE2L2 polymorphisms with glycemic control and late complications in patients with type 2 diabetes |
|---|
| Avtorji: | ID Vraničar, Zala (Avtor)
ID Goričar, Katja (Avtor)
ID Blagus, Tanja (Avtor)
ID Dolžan, Vita (Avtor)
ID Klen, Jasna (Avtor) |
|---|
| Datoteke: |  PDF - Predstavitvena datoteka, prenos (732,56 KB)
MD5: F1669F4B2C3F0E3A0E1B6DEC0F67D9D0
 URL - Izvorni URL, za dostop obiščite https://www.sciencedirect.com/science/article/pii/S0378111925004202?via%3Dihub
|
|---|
| Jezik: | Angleški jezik |
|---|
| Tipologija: | 1.01 - Izvirni znanstveni članek |
|---|
| Organizacija: |  UKC LJ - Univerzitetni klinični center Ljubljana
|
|---|
| Povzetek: | To investigate the association of KEAP1 rs1048290, rs9676881 and NFE2L2 rs6706649, rs6721961, rs35652124 polymorphisms with glycemic control and development of late complications in patients with type 2 diabetes mellitus (T2DM), a total of 316 T2DM patients were included in the retrospective genetic association study. Genotyping was performed using competitive allele-specific PCR. Data on HbA1c levels as a measure of glycemic control, and information on late complications, including ischemic heart disease, retinopathy, and nephropathy, was obtained from the medical records. Logistic regression analysis was used to assess the association between selected genetic polymorphisms and patients outcomes. Significant associations were observed between KEAP1 rs9676881 (p < 0.001) and NFE2L2 rs6721961 (p = 0.006) polymorphisms and elevated HbA1c levels. Additionally, NFE2L2 rs35652124 polymorphism was linked to a nominally higher risk of late complications, including ischemic heart disease (p = 0.036), retinopathy (p = 0.032), and nephropathy (p = 0.026). Results indicate that polymorphisms in the KEAP1 and NFE2L2 genes may influence glycemic control and the development of late complications in T2DM patients. These findings provide valuable insights into the genetic factors underlying T2DM progression and its complications in European populations, highlighting the potential role of genetic markers in optimizing personalized treatment strategies. |
|---|
| Ključne besede: | diabetes mellitus type 2, oxidative pathway, genetic polymorphism, microvascular complications, macrovascular complications, personalized medicine |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Leto izida: | 2025 |
|---|
| Št. strani: | str. 1-7 |
|---|
| Številčenje: | Vol. 964, [article no.] 149631 |
|---|
| PID: | 20.500.12556/DiRROS-24080  |
|---|
| UDK: | 616.3 |
|---|
| ISSN pri članku: | 1879-0038 |
|---|
| DOI: | 10.1016/j.gene.2025.149631 |
|---|
| COBISS.SI-ID: | 240248579 |
|---|
| Opomba: | Nasl. z nasl. zaslona;
Opis vira z dne 23. 6. 2025;
|
|---|
| Datum objave v DiRROS: | 11.11.2025 |
|---|
| Število ogledov: | 197 |
|---|
| Število prenosov: | 101 |
|---|
| Metapodatki: |    |
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
